Phosphorylation of Bcl2 and regulation of apoptosis

Leukemia

Volumn 15, Issue 4, 2001, Pages 515-522

  Ruvolo, P P ^a   Deng, X ^a   May, W S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Apoptosis; Bcl2; Bryostatin; Ceramide; IL 3; Signal transduction

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ANTINEOPLASTIC AGENT; BYOSTATIN 1; CARBOXYLIC ACID DERIVATIVE; CELL PROTEIN; DIACYLGLYCEROL; INTERLEUKIN 3; OKADAIC ACID; PACLITAXEL; PHOSPHATASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE; PROTEIN KINASE C INHIBITOR; RETINOIC ACID; SERINE; STAUROSPORINE; TAXANE DERIVATIVE; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; BONE MARROW CULTURE; CANCER CHEMOTHERAPY; CELL DEATH; CELL PROTECTION; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; DRUG RESISTANCE; DRUG RESPONSE; ENZYME ACTIVITY; ENZYME REGULATION; EUKARYOTIC CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OUTCOMES RESEARCH; PEDIATRICS; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SAMPLE; STRESS; SURVIVAL; TUMOR;

EID: 0035073292     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402090     Document Type: Review

References (101)

1. Bcl2 initiates a new category of oncogenes: Regulators of cell death
2. Molecular thanatopsis: A discourse on the Bcl2 family and cell death
3. Double identity for proteins of the Bcl2 family
4. The Bcl2 protein family: Arbiters of cell survival
5. Bcl2 family proteins
6. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14, 18) chromosome translocation
7. Cloning the chromosomal breakpoint of t(14, 18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18
8. Cloning and structural analysis of cDNAs for bcl2 and a hybrid bcl2/immunoglobulin transcript resulting from the t(14, 18) translocation
9. Bcl2 oncogene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
10. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death
11. Prevention of programmed cell death in Caendorhabditis elegans by human bcl2
12. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl2
13. Mechanisms of apoptotic cell death
14. Diverse molecular provocation of programmed cell death
15. Deregulated Bcl2 gene expression selectively prolongs survival of growth factor-deprived hematopoietic cell lines
16. Bcl2 affects survival but not neuronal differentiation of PC12 cells
17. Control of apoptosis by cytokines
18. Bcl2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
19. Bcl2 transgene inhibits T cell death and perturbs thymic self-censorship
20. Bcl2 interrupts the ceramide-mediated pathway of cell death
21. Bcl2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
22. Bcl2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells
23. High expression of Bcl2 protein in acute myeloid leukemia is associated with poor response to chemotherapy
24. Expression of the proto-oncogene bcl2 in the prostate and its association with androgen-independent prostate cancer
25. Bcl2 prevents death of factor deprived cells but fails to prevent apoptosis in targets of cell mediated killing
26. In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells
27. Clinical relevance of Bcl2 overexpression in childhood acute lymphoblastic leukemia
28. A functional role for mitochondrial PKC α in Bcl2 phosphorylation and suppression of apoptosis
29. Bcl2 protein in non-small-cell lung carcinoma
30. Bcl2 protein expression and long term survival in breast cancer
31. Bcl2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
32. Bax and PKC α modulate the prognostic impact of Bcl2 expression in acute myelogenous leukemia
33. The Baxα: Bcl2 ratio modulates the response to dexamethasone in leukemic cells and is highly variable in childhood acute leukaemia
34. Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of Bcl2a in association with suppression of apoptosis
35. Bcl2 phosphorylation required for anti-apoptosis function
36. Overexpressed full-length human Bcl2 extends the survival of bacuolovirus-infected SF9 insect cells
37. Role of protein kinase C in adriamycin-induced erythroid differentiation of K562 cells
38. Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine hematopoietic cells
39. The structure and biological function of the widely used inhibitor, H7, differs depending on commercial source
40. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases
41. Inactivation of Bcl2 by phosphorylation
42. Taxol-induced bcl2 phosphorylation and death of prostate cancer cells
43. Serine-70 is one of the critical sites for drug-induced bcl2 phosphorylation in cancer cells
44. Bcl2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G2/M
45. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway
46. Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death
47. Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells
48. Phosphorylation of Bcl2 after exposure of human leukemic cells to retinoic acid
49. Survival function of ERK1/2 as IL-3-activated staurosporine-resistant Bcl2 kinases
50. Deletion of the loop region of Bcl2 completely blocks paclitaxal-induced apoptosis
51. High levels of p26 Bcl2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells
52. Loss of the Bcl2 phosphorylation loop domain increases resistance to human leukemic cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis
53. Evolutionary conservation of function among mammalian, avian, and viral homologs of the Bcl2 oncoprotein
54. L and Bcl2
55. Deletion of a nonconserved region of Bcl2 confers a novel gain of function: Suppression of apoptosis with concomitant cell proliferation
56. Mitochondria and programmed cell death: Back to the future?
57. Bcl2 mutants with restricted subcellular location reveaal spatially distinct pathways for apoptosis in different cell types
58. Mitochondria and apoptosis
59. Functional dissection of the human Bcl2 protein: Sequence requirements for inhibition of apoptosis
60. Bcl2 undergoes phosphorylation by c-Jun N-terminal/stress-activated protein kinase in the presence of constitutively active GTP binding protein Rac-1
61. Angiotensin type 2 receptor dephosphorylates Bcl2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis
62. Reversible phosphorylation of Bcl2 following interleukin-3 or bryostatin-1 is mediated by direct interaction of protein phosphatase 2A
63. The sphingomyelin cycle and second messenger function of ceramide
64. Ceramide and the induction of apoptosis
65. Coordinate regulation of stress- and mitogen-activated protein kinases in apoptotic actions of ceramide and sphingosine
66. Ceramide activates the stress-activated protein kinases
67. Ceramide stimulates a cytosolic protein phosphatase 2A
68. Ceramide activates a heterotrimeric protein phosphatase 2A
69. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A
70. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
71. Sphingomyelin synthetase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation
72. Regulation of phosphoinositide-specific phospholipase C isozymes
73. Intracellular signaling: How do IP3 receptors work?
74. Protein kinase C: Structure, function, and regulation
75. Erythropoietin-induces Raf-1 activation and raf-1 is required for erythropoietin-mediated proliferation
76. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway
77. Ceramide synthetase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals
78. Ceramide inactivates cellular protein kinase C α
79. Mcl1 is phosphorylated by two distinct pathways, one through MAP kinase and the other protein phosphatase inhibition or microtubule damage
80. L is phosphorylated in malignant cells following microtubule disruption
81. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
82. Akt phosphorylation of BAD couples survival signals to the intrinsic death machinery
83. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A
84. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase
85. Bad, a heterodimeric partner for Bcl-XL and Bcl2, displaces Bax and promotes cell death
86. Serine threonine phosphorylation in cytokine signal transduction
87. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: Involvement of MEK upstream of Bad phosphorylation
88. L
89. Regulation of cell death protease caspase-9 by phosphorylation
90. Conversion of Bcl2 to a Bax-like death effector by caspases
91. Bcl2 and caspase inhibition cooperate to inhibit tumor necrosis factor-α-induced cell death in a Bcl2 cleavage-independent fashion
92. Modulation of cell death by Bcl-XL through caspase interaction
93. Caspases: Killer proteases
94. Purification and characterization of an interleukin-1b converting enzyme family of protease that activates cysteine protease p32
95. Induction of apoptotic program in cell free extracts: Requirement for dATP and cytochrome C
96. Dephosphorylation targets Bcl2 for ubiquitin-dependent degradation: A link between the apoptosome and proteasome pathway
97. L regulates apoptosis by heterodimerization-dependent and -independent mechanisms
98. Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia
99. Frequent incidence of somatic mutations in translocated Bcl2 oncogenes of non-Hodgkin's lymphomas
100. Morphological transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl2 gene
101. Bcl2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies